$TNYA 4 SEC Filings

Filed On	Filing
11 Sep 2026	Form 4: Ali Faraz, Director Received 122,000 shares as a grant or award · Granted 732,500 Stock Option (Right to buy)
11 Sep 2026	Form 4: Tingley Whittemore, Chief Medical Officer Received 49,000 shares as a grant or award · Granted 293,000 Stock Option (Right to buy)
17 Aug 2026	Form 4: Ali Faraz, Director Sold 22,232 shares ($15.8K)
17 Aug 2026	Form 4: Tingley Whittemore, Chief Medical Officer Sold 7,424 shares ($5.27K)
14 Jul 2026	Form 4: Hyllengren Eric J, Chief Financial Officer Granted 1,650,000 Stock Option (Right to buy)
29 May 2026	Form 4: Walsh Jeffrey T., Director Granted 120,000 Stock Option (Right to buy)
29 May 2026	Form 4: Williams R Sanders, Director Granted 120,000 Stock Option (Right to buy)
29 May 2026	Form 4: Stehman-Breen Catherine, Director Granted 120,000 Stock Option (Right to buy)
29 May 2026	Form 4: Srivastava Deepak, Director Granted 120,000 Stock Option (Right to buy)
29 May 2026	Form 4: Parschauer Karah Herdman, Director Granted 120,000 Stock Option (Right to buy)
29 May 2026	Form 4: Burroughs Amy L., Director Granted 120,000 Stock Option (Right to buy)
29 May 2026	Form 4: Lee June, Director Granted 120,000 Stock Option (Right to buy)
19 May 2026	Form 4: Ali Faraz, Director Sold 3,390 shares ($2.69K)
19 May 2026	Form 4: Tingley Whittemore, Chief Medical Officer Sold 3,121 shares ($2.48K)
19 May 2026	Form 4: Higa Tomohiro, SVP, Finance Sold 1,485 shares ($1.18K)
26 Feb 2026	Form 4: Column Group Iii GP, Lp, 10% owner and 7 others Sold 658,440 shares ($405K) · Sold 3,511,826 shares ($1.98M)
24 Feb 2026	Form 4: Column Group Iii GP, Lp, 10% owner and 7 others Sold 523,734 shares ($322K) · Sold 306,000 shares ($183K)
17 Feb 2026	Form 4: Higa Tomohiro, SVP, Finance Sold 3,469 shares ($2.23K)
17 Feb 2026	Form 4: Ali Faraz, Director Sold 14,862 shares ($9.56K)
17 Feb 2026	Form 4: Tingley Whittemore, Chief Medical Officer Sold 5,160 shares ($3.32K)

Comments